Dimethylamine

Dimethylamine

SCHEMBL1453283

CC1=Cc2c(-c3ccccc3)cccc2C1[Si](C)(C)C1C(C)=Cc2c(-c3ccccc3)cccc21.CNC

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.33
ALOX15 P16050 2/20 0.33
PDCD1 Q15116 1/20 0.32
CD274 Q9NZQ7 1/20 0.32
PDK2 Q15119 1/20 0.32
PDK4 Q16654 1/20 0.32
NTRK1 P04629 1/20 0.31
NTRK3 Q16288 1/20 0.31
ADRA2A P08913 2/20 0.31
ADRA2B P18089 2/20 0.31
ADRA2C P18825 2/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNA4 P43681 1/20 0.31
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HTR1A P08908 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29366427 0.95 PDCD1 (0.34) PDCD1CD274PDK2PDK4NTRK1
SCHEMBL61908 0.95 PDCD1 (0.34) PDCD1CD274PDK2PDK4NTRK1
Hydrochloric Acid SCHEMBL3822639 0.93 ADRA2A (0.34) TDO2PDCD1CD274ADRA2AADRA2B
SCHEMBL16683341 0.89 PDCD1 (0.30) PDCD1CD274NTRK1NTRK3
SCHEMBL1452295 0.89 PDCD1 (0.30) PDCD1CD274
SCHEMBL6056122 0.89 PDCD1 (0.30) PDCD1CD274
SCHEMBL7050759 0.88 PDCD1 (0.35) PDCD1CD274PDK2PDK4NTRK1
SCHEMBL1452790 0.87 MAPK1 (0.39) NPC1ALDH1A1RAB9ASMN1; SMN2HTR1A
SCHEMBL5838399 0.87 PDK2 (0.31) PDK2PDK4
SCHEMBL7053161 0.86 PDCD1 (0.34) PDCD1CD274PDK2PDK4NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7910783-B2 Preparation of substituted bridged indenyl and related ligands EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-03-22 US disclosed
US-20070135596-A1 Preparation of substituted bridged indenyl and related ligands EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135596-A1 Preparation of substituted bridged indenyl and related ligands SP1, TTL, TTLL12 TDO2 958/4885ALOX15 4554/4885PDCD1 2366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.